Get waivered remote: Nationwide, remote DEA-x waiver course in response to COVID-19

PROBLEM: As of 2020, less than 5% of physicians in the United States have a drug enforcement administration-X waiver to prescribe buprenorphine. The coronavirus-2019 pandemic restricted in-person gatherings, including traditional drug enforcement administration-X waiver courses. As a result, in-pers...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Alister, Raber, Joshua P., Shayer, Desiree, Lai, Deborah, Goodcoff, Adam, Kannikal, Jasmine, Raja, Ali S., He, Shuhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529309/
https://www.ncbi.nlm.nih.gov/pubmed/34691756
http://dx.doi.org/10.1177/20552076211048985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529309/
https://www.ncbi.nlm.nih.gov/pubmed/34691756
http://dx.doi.org/10.1177/20552076211048985

Ejemplares similares